ACOMS+ 및 학술지 리포지터리 설명회

  • 한국과학기술정보연구원(KISTI) 서울분원 대회의실(별관 3층)
  • 2024년 07월 03일(수) 13:30
 

  • P-ISSN2233-4203
  • E-ISSN2093-8950
  • ESCI, SCOPUS, KCI

논문 상세

Home > 논문 상세
  • P-ISSN 2233-4203
  • E-ISSN 2093-8950

Preparation and Characterization of Quercetin-Loaded Solid Dispersion by Solvent Evaporation and Freeze-Drying Method

Mass Spectrometry Letters / Mass Spectrometry Letters, (P)2233-4203; (E)2093-8950
2016, v.7 no.3, pp.79-83
https://doi.org/10.5478/MSL.2016.7.3.79
Sang Hyun Park (Dankook University)
Im-Sook Song (Kyungpook National University)
Min-Koo Choi (Dankook University)
  • 다운로드 수
  • 조회수

Abstract

We prepared solid dispersion formulations of quercetin to enhance its solubility and dissolution rate. Various quercetinloaded solid dispersion were tested with quercetin, poloxamer 407, and carrier such as hydroxypropyl methyl cellulose (HPMC), polyethylene glycol 8000 (PEG 8000), and polyvinylpyrrolidone K40 (PVP K40) using solvent evaporation and freeze drying methods in terms of both the aqueous solubility and the dissolution rates of quercetin. The solubility of quercetin as its solid dispersion formulations was markedly improved compared with that of quercetin powder. Especially, highest solubility of quercetin was observed when HPMC was used as a carrier. The cumulative dissolution of quercetin within 360 min from solid dispersion composed of quercetin, poloxamer 407, and HPMC was 8.8-fold higher than the dissolution of pure quercetin. The results of powder Xray diffraction (XRD) and scanning electron microscope (SEM) indicated that quercetin transformed from a crystalline to an amorphous form through the solid dispersion formulation process. These results suggest that the solid dispersion formulation of quercetin with poloxamer 407 and HPMC could be a promising option for enhancing the solubility and dissolution rate of quercetin.

keywords
quercetin, HPMC, solid dispersion, solubility, dissolution


참고문헌

1

Jagtap, S.. (2009). . Curr. Med. Chem, 16, 1451-.

2

Christine, B. S.. (2012). . Pharmacol. Res, 65, 523-.

3

Vasanthi, H. R.. (2012). . Curr. Med. Chem, 19, 2242-.

4

Kakran, M.. (2011). . Colloids Surf. B Biointerfaces, 88, 121-.

5

Seo, S. W.. (2012). . Int. J. Pharm, 424, 18-.

6

Craig, D. Q.. (2002). . Int. J. Pharm, 231, 131-.

7

Bikiaris, D. N.. (2011). . Expert Opin. Drug Deliv, 8, 1501-.

8

Ni, B.. (2016). . J. Chromatogr. Sci, 54, 1359-.

9

Pralhad, T.. (2004). . J. Pharm. Biomed. Anal, 34, 333-.

10

Cai, X.. (2013). . Curr. Med. Chem, 20, 2572-.

11

Guo, Y.. (2015). . J. Nutr. Biochem, 26, 201-.

12

Woo, B. H.. (2001). . J. Control. Release, 75, 307-.

투고일Submission Date
2016-09-13
수정일Revised Date
2016-09-26
게재확정일Accepted Date
2016-09-27
상단으로 이동

Mass Spectrometry Letters